Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
RAF1 | MAP2K2 | MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki | 1.14E5 | Evidence | O | ||||
RAF1 | YWHAB | YWHAB: 14-3-3 protein beta/alpha | 2.65E4 | Evidence | O | ||||
RAF1 | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 1.88E4 | Evidence | |||||
RAF1 | MAP2K1 | MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 | 3.26E3 | Evidence | O | ||||
RAF1 | RAP1B | RAP1B, OK/SW-cl.11: Ras-related protein Rap-1b precursor | 317.0 | Evidence | |||||
RAF1 | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 115.0 | Evidence | |||||
RAF1 | NRAS | NRAS, HRAS1: GTPase NRas precursor | 114.0 | Evidence | O | ||||
RAF1 | RPS6KA1 | RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 | 105.0 | Evidence | |||||
RAF1 | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 105.0 | Evidence | |||||
RAF1 | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 105.0 | Evidence | O | ||||
RAF1 | NCK2 | NCK2: Cytoplasmic protein NCK2 | 85.20 | Evidence | |||||
RAF1 | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 69.40 | Evidence | |||||
RAF1 | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 69.40 | Evidence | |||||
RAF1 | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 69.40 | Evidence | |||||
RAF1 | STK38 | STK38, NDR1: Serine/threonine-protein kinase 38 | 64.00 | Evidence | |||||
RAF1 | CSK | CSK: Tyrosine-protein kinase CSK | 64.00 | Evidence | |||||
RAF1 | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 64.00 | Evidence | |||||
RAF1 | RGS2 | RGS2, G0S8: Regulator of G-protein signaling 2 | 59.5 | Evidence | |||||
RAF1 | RAC2 | RAC2: Ras-related C3 botulinum toxin substrate 2 precursor | 58.90 | Evidence | |||||
RAF1 | LYN | LYN: Tyrosine-protein kinase Lyn | 55.10 | Evidence | |||||
RAF1 | SYK | SYK: Tyrosine-protein kinase SYK | 55.10 | Evidence | |||||
RAF1 | CSNK2A1 | CSNK2A1: CSNK2A1 protein | 51.60 | Evidence | |||||
RAF1 | STK38L | STK38L, KIAA0965, NDR2: Serine/threonine-protein kinase 38-like | 51.60 | Evidence | |||||
RAF1 | MAPK1 | MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 | 51.60 | Evidence | |||||
RAF1 | CRKL | CRKL: Crk-like protein | 51.60 | Evidence | |||||
RAF1 | BRAF | BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase | 51.50 | Evidence | O | ||||
RAF1 | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 51.50 | Evidence | |||||
RAF1 | ADRBK1 | ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 | 44.40 | Evidence | |||||
RAF1 | COPE | COPE: Coatomer subunit epsilon | 43.00 | Evidence | |||||
RAF1 | VAV1 | VAV1, VAV: Proto-oncogene vav | 42.00 | Evidence | O | ||||
RAF1 | SH3BP5 | N/A | 39.10 | Evidence | |||||
RAF1 | PRKCI | PRKCI, DXS1179E: Protein kinase C iota type | 39.10 | Evidence | |||||
RAF1 | CD44 | N/A | 35.00 | Evidence | |||||
RAF1 | IRS2 | IRS2: Insulin receptor substrate 2 | 34.80 | Evidence | |||||
RAF1 | DUSP1 | DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 | 34.00 | Evidence | |||||
RAF1 | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 33.90 | Evidence | O | ||||
RAF1 | PIP5K3 | PIP5K3, KIAA0981, PIKFYVE: FYVE finger-containing phosphoinositide kinase | 32.30 | Evidence | |||||
RAF1 | DAPK1 | DAPK1, DAPK: Death-associated protein kinase 1 | 31.20 | Evidence | |||||
RAF1 | CDK5 | CDK5: Cell division protein kinase 5 | 31.20 | Evidence | |||||
RAF1 | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 30.90 | Evidence | |||||
RAF1 | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 30.00 | Evidence | O | ||||
RAF1 | IRAK1 | IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 | 27.80 | Evidence | |||||
RAF1 | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 26.40 | Evidence | |||||
RAF1 | CDC23 | CDC23: Cell division cycle protein 23 homolog | 26.00 | Evidence | |||||
RAF1 | PRKX | PRKX, PKX1: Serine/threonine-protein kinase PRKX | 25.00 | Evidence | |||||
RAF1 | YWHAG | YWHAG: 14-3-3 protein gamma | 22.90 | Evidence | O | ||||
RAF1 | SNCA | SNCA, NACP, PARK1: Alpha-synuclein | 22.90 | Evidence | |||||
RAF1 | UTX | UTX: Ubiquitously transcribed X chromosome tetratricopeptide repeat protein | 22.40 | Evidence | |||||
RAF1 | PPID | PPID, CYP40, CYPD: 40 kDa peptidyl-prolyl cis-trans isomerase | 22.40 | Evidence | |||||
RAF1 | PLEKHA5 | PLEKHA5, KIAA1686, PEPP2: Pleckstrin homology domain-containing family A member | 22.40 | Evidence | |||||
RAF1 | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 22.30 | Evidence | |||||
RAF1 | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 22.20 | Evidence | |||||
RAF1 | HSP90AB1 | HSP90AB1, HSP90B, HSPC2, HSPCB: Heat shock protein HSP 90-beta | 21.40 | Evidence | O | ||||
RAF1 | PRKACA | PRKACA, PKACA: cAMP-dependent protein kinase, alpha-catalytic subunit | 20.50 | Evidence | |||||
RAF1 | RPS6KA4 | RPS6KA4, MSK2: Ribosomal protein S6 kinase alpha-4 | 20.50 | Evidence | |||||
RAF1 | DUSP6 | DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 | 20.50 | Evidence | |||||
RAF1 | CDC25A | CDC25A: M-phase inducer phosphatase 1 | 20.50 | Evidence | |||||
RAF1 | MKNK1 | MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 | 20.50 | Evidence | |||||
RAF1 | CDC25C | CDC25C: M-phase inducer phosphatase 3 | 20.50 | Evidence | |||||
RAF1 | RPS6KA2 | RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 | 20.50 | Evidence | |||||
RAF1 | PDPK1 | PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 | 20.50 | Evidence | |||||
RAF1 | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 20.50 | Evidence | |||||
RAF1 | STMN1 | STMN1, LAP18, OP18: Stathmin | 20.40 | Evidence | |||||
RAF1 | PPP2R5A | PPP2R5A: Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha | 20.20 | Evidence | |||||
RAF1 | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 20.00 | Evidence | |||||
RAF1 | MAPK8 | MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 | 19.70 | Evidence | |||||
RAF1 | MINK1 | MAP4K6, MINK1, MINK: Misshapen-like kinase 1 | 19.70 | Evidence | |||||
RAF1 | CASP9 | CASP9, MCH6: Caspase-9 precursor | 19.10 | Evidence | |||||
RAF1 | RIN1 | RIN1: Ras and Rab interactor 1 | 18.90 | Evidence | |||||
RAF1 | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 18.70 | Evidence | |||||
RAF1 | RPS6KA3 | RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 | 18.50 | Evidence | |||||
RAF1 | GAB1 | GAB1: GRB2-associated-binding protein 1 | 18.10 | Evidence | |||||
RAF1 | DUSP16 | DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 | 17.60 | Evidence | |||||
RAF1 | SPTBN1 | SPTBN1, SPTB2: Spectrin beta chain, brain 1 | 17.60 | Evidence | |||||
RAF1 | STAT3 | 17.60 | Evidence | ||||||
RAF1 | HLA-C | HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor | 16.80 | Evidence | |||||
RAF1 | GABRR1 | N/A | 16.60 | Evidence | |||||
RAF1 | DUSP3 | DUSP3, VHR: Dual specificity protein phosphatase 3 | 16.40 | Evidence | |||||
RAF1 | PGAM1 | PGAM1, PGAMA, CDABP0006: Phosphoglycerate mutase 1 | 15.80 | Evidence | |||||
RAF1 | DNAJC7 | DNAJC7, TPR2, TTC2: DnaJ homolog subfamily C member 7 | 15.70 | Evidence | |||||
RAF1 | CDKN1B | CDKN1B, KIP1: Cyclin-dependent kinase inhibitor 1B | 15.30 | Evidence | |||||
RAF1 | NAP1L1 | NAP1L1, NRP: Nucleosome assembly protein 1-like 1 | 15.30 | Evidence | |||||
RAF1 | SNCG | SNCG, BCSG1, PERSYN, PRSN: Gamma-synuclein | 15.30 | Evidence | |||||
RAF1 | MAP3K14 | MAP3K14, NIK: Mitogen-activated protein kinase kinase kinase 14 | 15.10 | Evidence | |||||
RAF1 | PTPRR | PTPRR, ECPTP, PTPRQ: Receptor-type tyrosine-protein phosphatase R precursor | 15.10 | Evidence | |||||
RAF1 | IRS1 | IRS1: Insulin receptor substrate 1 | 15.00 | Evidence | |||||
RAF1 | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 13.70 | Evidence | O | ||||
RAF1 | PLCB1 | PLCB1, KIAA0581: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta- | 13.70 | Evidence | |||||
RAF1 | PRKCG | PRKCG, PKCG: Protein kinase C gamma type | 13.50 | Evidence | |||||
RAF1 | STMN2 | STMN2, SCG10, SCGN10: Stathmin-2 | 13.50 | Evidence | |||||
RAF1 | GSK3A | GSK3A: Glycogen synthase kinase-3 alpha | 13.50 | Evidence | |||||
RAF1 | PAK4 | PAK4, KIAA1142: Serine/threonine-protein kinase PAK 4 | 13.50 | Evidence | |||||
RAF1 | PARD6A | PARD6A, PAR6A: Partitioning defective 6 homolog alpha | 13.40 | Evidence | |||||
RAF1 | JUND | JUND: Transcription factor jun-D | 13.30 | Evidence | |||||
RAF1 | GRIN1 | GRIN1, NMDAR1: Glutamate [NMDA] receptor subunit zeta-1 precursor | 13.20 | Evidence | |||||
RAF1 | RAB4A | N/A | 13.00 | Evidence | |||||
RAF1 | PTPRE | PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor | 13.00 | Evidence | |||||
RAF1 | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 13.00 | Evidence | |||||
RAF1 | KRT1 | KRT1, KRTA: Keratin, type II cytoskeletal 1 | 12.50 | Evidence | |||||
RAF1 | PTGIR | PTGIR, PRIPR: Prostacyclin receptor | 12.40 | Evidence | |||||
RAF1 | PRKCZ | PRKCZ, PKC2: Protein kinase C zeta type | 12.10 | Evidence | O | ||||
RAF1 | EPB41L3 | EPB41L3, DAL1, KIAA0987: Band 4.1-like protein 3 | 12.10 | Evidence | |||||
RAF1 | MICAL-L1 | MICALL1, KIAA1668, MIRAB13: MICAL-like protein 1 | 11.90 | Evidence | |||||
RAF1 | UBAP2 | N/A | 11.80 | Evidence | |||||
RAF1 | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 11.60 | Evidence | |||||
RAF1 | NEK8 | NEK8, JCK, NEK12A: Serine/threonine-protein kinase Nek8 | 11.60 | Evidence | |||||
RAF1 | CDC2L1 | CDC2L1, PITSLREA, PK58: PITSLRE serine/threonine-protein kinase CDC2L1 | 11.50 | Evidence | |||||
RAF1 | NCF2 | NCF2: Neutrophil cytosol factor 2 | 11.50 | Evidence | |||||
RAF1 | MGMT | MGMT: Methylated-DNA--protein-cysteine methyltransferase | 11.5 | Evidence | |||||
RAF1 | RHOB | RHOB, ARH6, ARHB: Rho-related GTP-binding protein RhoB precursor | 11.20 | Evidence | |||||
RAF1 | PIK4CB | PIK4CB, RP11-126K1.4-003, hCG_1811976: Phosphatidylinositol 4-kinase, catalytic, | 10.80 | Evidence | |||||
RAF1 | TESK1 | TESK1: Dual specificity testis-specific protein kinase 1 | 10.60 | Evidence | |||||
RAF1 | EPRS | EPRS, GLNS, PARS, QARS, QPRS: Bifunctional aminoacyl-tRNA synthetase [Includes: | 10.60 | Evidence | |||||
RAF1 | CHC1 | RCC1: RCC1-I (Fragment) | 10.50 | Evidence | |||||
RAF1 | LRRC7 | LRRC7, KIAA1365, LAP1: Leucine-rich repeat-containing protein 7 | 10.30 | Evidence | |||||
RAF1 | RASGRP2 | RASGRP2: RAS guanyl-releasing protein 2 | 10.30 | Evidence | |||||
RAF1 | TSC2 | TSC2, TSC4: Tuberin | 10.30 | Evidence | |||||
RAF1 | STAM2 | STAM2: Signal transducing adapter molecule 2 | 10.30 | Evidence | |||||
RAF1 | RNPS1 | RNPS1, LDC2: RNA-binding protein with serine-rich domain 1 | 10.20 | Evidence | |||||
RAF1 | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 10.10 | Evidence | |||||
RAF1 | AMPH | AMPH, AMPH1: Amphiphysin | 9.96 | Evidence | |||||
RAF1 | MAPK7 | mitogen-activated protein kinase 7 isoform 1 | 9.76 | Evidence | |||||
RAF1 | MARK2 | N/A | 9.76 | Evidence | |||||
RAF1 | PAPOLA | PAPOLA, PAP: Poly(A) polymerase alpha | 9.17 | Evidence | |||||
RAF1 | CBX3 | CBX3: Chromobox protein homolog 3 | 9.15 | Evidence | |||||
RAF1 | MAD1L1 | MAD1L1, MAD1, TXBP181: Mitotic spindle assembly checkpoint protein MAD1 | 8.74 | Evidence | |||||
RAF1 | BCL2 | BCL2: Apoptosis regulator Bcl-2 | 8.69 | Evidence | |||||
RAF1 | BCL2L1 | BCL2L1, BCL2L, BCLX: Apoptosis regulator Bcl-X | 7.72 | Evidence | |||||
RAF1 | JUN | JUN: Transcription factor AP-1 | 7.56 | Evidence | |||||
RAF1 | HSF1 | HSF1, HSTF1: Heat shock factor protein 1 | 7.56 | Evidence | |||||
RAF1 | RPA2 | RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit | 7.52 | Evidence | |||||
RAF1 | FOS | FOS, G0S7: Proto-oncogene protein c-fos | 7.38 | Evidence | |||||
RAF1 | SMARCA5 | SMARCA5, SNF2H, WCRF135: SWI/SNF-related matrix-associated actin-dependent regul | 7.38 | Evidence | |||||
RAF1 | MNAR | PELP1, HMX3, MNAR: Proline-, glutamic acid- and leucine-rich protein 1 | 7.20 | Evidence | |||||
RAF1 | PTPRA | N/A | 7.14 | Evidence | |||||
RAF1 | KIT | KIT: Mast/stem cell growth factor receptor precursor | 7.05 | Evidence | |||||
RAF1 | BID | BID: BH3-interacting domain death agonist | 6.82 | Evidence | |||||
RAF1 | PARD3 | N/A | 6.81 | Evidence | |||||
RAF1 | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 6.80 | Evidence | |||||
RAF1 | EPOR | EPOR: Erythropoietin receptor precursor | 6.78 | Evidence | |||||
RAF1 | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 6.73 | Evidence | O | ||||
RAF1 | AQP2 | AQP2: Aquaporin-2 | 6.66 | Evidence | |||||
RAF1 | SORBS3 | SORBS3, SCAM1: Vinexin | 6.66 | Evidence | |||||
RAF1 | INSR | INSR: Insulin receptor precursor | 6.63 | Evidence | |||||
RAF1 | TUBB | TUBB, TUBB5, OK/SW-cl.56: Tubulin beta chain | 6.50 | Evidence | |||||
RAF1 | PSMC2 | PSMC2, MSS1: 26S protease regulatory subunit 7 | 6.45 | Evidence | |||||
RAF1 | SF1 | SF1, ZFM1, ZNF162: Splicing factor 1 | 6.40 | Evidence | |||||
RAF1 | PPP1R12C | PPP1R12C, MBS85: Protein phosphatase 1 regulatory subunit 12C | 6.40 | Evidence | |||||
RAF1 | SLC9A3R2 | SLC9A3R2: SLC9A3R2 protein (Fragment) | 6.40 | Evidence | |||||
RAF1 | TH | TH, TYH: Tyrosine 3-monooxygenase | 6.39 | Evidence | |||||
RAF1 | GRB10 | N/A | 6.14 | Evidence | |||||
RAF1 | RASGRF1 | RASGRF1, CDC25: Guanine nucleotide-releasing protein | 6.11 | Evidence | |||||
RAF1 | TUBA1 | TUBA4A, TUBA1: Tubulin alpha-4A chain | 6.06 | Evidence | |||||
RAF1 | EP300 | N/A | 6.01 | Evidence | |||||
RAF1 | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 5.97 | Evidence | |||||
RAF1 | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 5.97 | Evidence | |||||
RAF1 | PEA15 | PEA15: Astrocytic phosphoprotein PEA-15 | 5.90 | Evidence | |||||
RAF1 | AHNAK | AHNAK: AHNAK protein | 5.9 | Evidence | |||||
RAF1 | PRKACG | PRKACG: cAMP-dependent protein kinase, gamma-catalytic subunit | 5.89 | Evidence | |||||
RAF1 | LSP1 | LSP1, WP34: Lymphocyte-specific protein 1 | 5.87 | Evidence | |||||
RAF1 | HSPB8 | HSPB8, CRYAC, PP1629, E2IG1, HSP22: Heat shock protein beta-8 | 5.86 | Evidence | |||||
RAF1 | HSPA8 | HSPA8, HSC70, HSP73, HSPA10: Heat shock cognate 71 kDa protein | 5.73 | Evidence | |||||
RAF1 | DPP8 | DPP8, DPRP1, MSTP097, MSTP135, MSTP141: Dipeptidyl peptidase 8 | 5.73 | Evidence | |||||
RAF1 | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 5.63 | Evidence | |||||
RAF1 | PTPN11 | N/A | 5.55 | Evidence | |||||
RAF1 | FKBP1A | FKBP1A, FKBP1, FKBP12: FK506-binding protein 1A | 5.55 | Evidence | |||||
RAF1 | TAF10 | TAF2A, TAF10, TAF2H, TAFII30: Transcription initiation factor TFIID subunit 10 | 5.54 | Evidence | |||||
RAF1 | KIAA0788 | ASCC3L1, HELIC2, KIAA0788: U5 small nuclear ribonucleoprotein 200 kDa helicase | 5.54 | Evidence | |||||
RAF1 | TDG | TDG: G/T mismatch-specific thymine DNA glycosylase | 5.54 | Evidence | |||||
RAF1 | TOP2B | N/A | 5.32 | Evidence | |||||
RAF1 | RACGAP1 | RACGAP1, KIAA1478, MGCRACGAP: Rac GTPase-activating protein 1 | 5.28 | Evidence | |||||
RAF1 | ADAM33 | ADAM33, UNQ873/PRO1891: ADAM 33 precursor | 5.26 | Evidence | |||||
RAF1 | NPPC | NPPC, CNP2: C-type natriuretic peptide precursor [Contains: CNP-22; CNP-29; CNP- | 5.08 | Evidence | |||||
RAF1 | PPP1R8 | N/A | 4.77 | Evidence | |||||
RAF1 | SMAD2 | SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 | 4.77 | Evidence | |||||
RAF1 | TPH1 | N/A | 4.69 | Evidence | |||||
RAF1 | GNA12 | GNA12: Guanine nucleotide-binding protein alpha-12 subunit | 4.63 | Evidence | |||||
RAF1 | KRT18 | KRT18: Uncharacterized protein KRT18 | 4.48 | Evidence | |||||
RAF1 | LEPR | LEPR, DB, OBR: Leptin receptor precursor | 4.48 | Evidence | |||||
RAF1 | ZFP36 | ZFP36, G0S24, RNF162A, TIS11A, TTP: Tristetraproline | 4.47 | Evidence | |||||
RAF1 | MDM4 | MDM4, MDMX: Mdm4 protein | 4.38 | Evidence | |||||
RAF1 | NDP | NDP: Norrin precursor | 4.35 | Evidence | |||||
RAF1 | UBTF | UBTF, UBF, UBF1: Nucleolar transcription factor 1 | 4.30 | Evidence | |||||
RAF1 | ATP1A1 | ATP1A1: Sodium/potassium-transporting ATPase subunit alpha-1 precursor | 4.28 | Evidence | |||||
RAF1 | CASP3 | CASP3, CPP32: Caspase-3 precursor | 4.23 | Evidence | |||||
RAF1 | GJA1 | GJA1, GJAL: Gap junction alpha-1 protein | 4.23 | Evidence | |||||
RAF1 | ARAF | ARAF, ARAF1, PKS, PKS2: A-Raf proto-oncogene serine/threonine-protein kinase | 4.22 | Evidence | |||||
RAF1 | IKBKE | IKBKE, IKKE, IKKI, KIAA0151: Inhibitor of nuclear factor kappa-B kinase subunit | 4.19 | Evidence | |||||
RAF1 | C1QBP | C1QBP, GC1QBP, HABP1, SF2P32: Complement component 1 Q subcomponent-binding prot | 4.19 | Evidence | |||||
RAF1 | DUSP2 | DUSP2, PAC1: Dual specificity protein phosphatase 2 | 4.16 | Evidence | |||||
RAF1 | TSC1 | TSC1, KIAA0243, TSC: Hamartin | 4.01 | Evidence | |||||
RAF1 | GRIN2A | GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor | 3.9 | Evidence | |||||
RAF1 | MATK | 3.88 | Evidence | ||||||
RAF1 | PTPN7 | N/A | 3.88 | Evidence | |||||
RAF1 | TP53 | TP53, P53: Cellular tumor antigen p53 | 3.85 | Evidence | |||||
RAF1 | CEBPB | CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta | 3.85 | Evidence | |||||
RAF1 | GRAP | GRAP: GRB2-related adapter protein | 3.83 | Evidence | |||||
RAF1 | NPR3 | NPR3, ANPRC: Atrial natriuretic peptide clearance receptor precursor | 3.78 | Evidence | |||||
RAF1 | OSBPL6 | OSBPL6, ORP6: Oxysterol-binding protein-related protein 6 | 3.70 | Evidence | |||||
RAF1 | ARHGEF1 | ARHGEF1: Rho guanine nucleotide exchange factor 1 | 3.70 | Evidence | |||||
RAF1 | DUSP10 | DUSP10, MKP5: Dual specificity protein phosphatase 10 | 3.70 | Evidence | |||||
RAF1 | GJB1 | GJB1, CX32: Gap junction beta-1 protein | 3.64 | Evidence | |||||
RAF1 | MST1R | MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor | 3.62 | Evidence | |||||
RAF1 | BAD | BAD, BBC6, BCL2L8: Bcl2 antagonist of cell death | 3.51 | Evidence | |||||
RAF1 | NGFR | NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor | 3.48 | Evidence | |||||
RAF1 | RAD51 | RAD51, RAD51A, RECA: DNA repair protein RAD51 homolog 1 | 3.47 | Evidence | |||||
RAF1 | FBXO4 | FBXO4, FBX4: F-box only protein 4 | 3.34 | Evidence | |||||
RAF1 | PAK1IP1 | PAK1IP1, PIP1, WDR84: p21-activated protein kinase-interacting protein 1 | 3.30 | Evidence | |||||
RAF1 | TUBB2A | TUBB2A, TUBB2: Tubulin beta-2A chain | 3.27 | Evidence | |||||
RAF1 | PEBP1 | PEBP1, PBP, PEBP: Phosphatidylethanolamine-binding protein 1 | 3.26 | Evidence | O | ||||
RAF1 | KRT8 | KRT8, CYK8: Keratin, type II cytoskeletal 8 | 3.07 | Evidence | |||||
RAF1 | ST3GAL1 | ST3GAL1, SIAT4, SIAT4A: CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sia | 3.02 | Evidence | |||||
RAF1 | MAP2K3 | N/A | 2.99 | Evidence | |||||
RAF1 | EGF | EGF: Pro-epidermal growth factor precursor | 2.94 | Evidence | |||||
RAF1 | CHRM2 | CHRM2: Muscarinic acetylcholine receptor M2 | 2.85 | Evidence | |||||
RAF1 | HIF1A | HIF1A, MOP1: Hypoxia-inducible factor 1 alpha | 2.84 | Evidence | |||||
RAF1 | HDAC4 | HDAC4, KIAA0288: Histone deacetylase 4 | 2.84 | Evidence | |||||
RAF1 | TCF3 | TCF3, E2A, ITF1: Transcription factor E2-alpha | 2.84 | Evidence | |||||
RAF1 | SMAD4 | SMAD4, DPC4, MADH4: Mothers against decapentaplegic homolog 4 | 2.70 | Evidence | |||||
RAF1 | FOSL2 | FOSL2, FRA2: Fos-related antigen 2 | 2.70 | Evidence | |||||
RAF1 | BCAR1 | BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 | 2.34 | Evidence | |||||
RAF1 | ETS1 | ETS1, EWSR2: Protein C-ets-1 | 2.33 | Evidence | |||||
RAF1 | PTPNS1 | N/A | 2.29 | Evidence | |||||
RAF1 | REM1 | REM1, GES, REM: GTP-binding protein REM 1 | 2.18 | Evidence | |||||
RAF1 | LOC642558 | FUSIP1, FUSIP2, TASR: FUS-interacting serine-arginine-rich protein 1 | 1.98 | Evidence | |||||
RAF1 | NFIA | NFIA, RP5-902P15.1-003, hCG_2032260: Nuclear factor I/A | 1.98 | Evidence | |||||
RAF1 | DUSP4 | DUSP4, MKP2, VH2: Dual specificity protein phosphatase 4 | 1.94 | Evidence | |||||
RAF1 | PARVA | PARVA, MXRA2: Alpha-parvin | 1.84 | Evidence | |||||
RAF1 | MAPT | N/A | 1.81 | Evidence | |||||
RAF1 | TAL2 | TAL2: T-cell acute lymphocytic leukemia protein 2 | 1.78 | Evidence | |||||
RAF1 | ENO2 | ENO2: Gamma-enolase | 1.77 | Evidence | |||||
RAF1 | GRIN2D | GRIN2D, NMDAR2D: Glutamate [NMDA] receptor subunit epsilon-4 precursor | 1.71 | Evidence | |||||
RAF1 | NES | N/A | 1.71 | Evidence | |||||
RAF1 | RAVER1 | RAVER1, KIAA1978: Ribonucleoprotein PTB-binding 1 | 1.71 | Evidence | |||||
RAF1 | IRF7 | N/A | 1.71 | Evidence | |||||
RAF1 | JDP2 | jdp2, JDP2: Jun dimerization protein 2 | 1.71 | Evidence | |||||
RAF1 | ARPC4 | ARPC4, ARC20: Actin-related protein 2/3 complex subunit 4 | 1.69 | Evidence | |||||
RAF1 | NR4A2 | NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 | 1.64 | Evidence | |||||
RAF1 | SAP14 | SF3B14, CGI-110, HSPC175, HT006: Pre-mRNA branch site protein p14 | 1.53 | Evidence | |||||
RAF1 | MAPK8IP3 | N/A | 1.53 | Evidence | |||||
RAF1 | SMAD7 | SMAD7, MADH7, MADH8: Mothers against decapentaplegic homolog 7 | 1.48 | Evidence | |||||
RAF1 | TAL1 | TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 | 1.41 | Evidence | |||||
RAF1 | PRKACB | N/A | 1.33 | Evidence | |||||
RAF1 | ZNF295 | ZNF295, KIAA1227, ZBTB21: Zinc finger protein 295 | 1.30 | Evidence | |||||
RAF1 | PPARA | PPARA, NR1C1, PPAR: Peroxisome proliferator-activated receptor alpha | 1.27 | Evidence | |||||
RAF1 | ZA20D1 | OTUD7B, ZA20D1: OTU domain-containing protein 7B | 1.21 | Evidence | |||||
RAF1 | CTSZ | CTSZ: Cathepsin Z precursor | 1.19 | Evidence | |||||
RAF1 | HDAC5 | HDAC5, KIAA0600: Histone deacetylase 5 | 1.17 | Evidence | |||||
RAF1 | ELK1 | ELK1: ETS domain-containing protein Elk-1 | 1.17 | Evidence | |||||
RAF1 | HNRPD | HNRPD, AUF1: Heterogeneous nuclear ribonucleoprotein D0 | 1.16 | Evidence | |||||
RAF1 | ESR1 | ESR1, ESR, NR3A1: Estrogen receptor | 1.14 | Evidence | |||||
RAF1 | GP5 | GP5: Platelet glycoprotein V precursor | 1.00 | Evidence |